Evolent Health, Inc. EVH Reportable segment — Loss from equity method investees
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s reportable segment — loss from equity method investees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s reportable segment — loss from equity method investees?
- Evolent Health, Inc. (EVH) reported reportable segment — loss from equity method investees of -$11K in Q1 2026.
- How has Evolent Health, Inc.'s reportable segment — loss from equity method investees changed year-over-year?
- Evolent Health, Inc.'s reportable segment — loss from equity method investees increased by 42.1% year-over-year, from -$19K to -$11K.
- What is the long-term trend for Evolent Health, Inc.'s reportable segment — loss from equity method investees?
- Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — loss from equity method investees has grown at a -56.9% compound annual growth rate (CAGR), from $4.57M to $365K.
- What does reportable segment — loss from equity method investees mean?
- This reflects the segment's proportional share of losses from entities in which it holds a significant influence but not full control. It highlights the financial performance of strategic partnerships and joint ventures within the segment's ecosystem.